An ex vivo method for removal of tumor cells from intra-operatively salvaged blood
OwnerHorst Lindhofer, Franzpeter Bracht +1inventors
InventorsHorst Lindhofer, Franzpeter Bracht, Markus Heiss
Life of this patent
Estimating the term…
Abstract
The present invention relates to an ex vivo method for removal of tumor cells from intra-operatively salvaged blood which comprises contacting a trifunctional antibody with said blood to form aggregates or associates of antibody, tumor cells and immune cells, centrifuging to obtain an erythrocyte concentrate, and filtering to remove said aggregates or associates and residual antibody from said erythrocyte concentrate.
Claims15
An ex vivo method for removal of tumor cells from intra-operatively salvaged blood comprising the following steps:
- (i) collecting an intra-operatively salvaged blood which may contain immune cells and tumor cells in a reservoir;
- (ii) contacting said intra-operatively salvaged blood from step (I) in the reservoir with at least one trifunctional antibody and/or with a scaffold protein, wherein said antibody or said scaffold protein comprises the following properties:
- a) binding to a T cell;
- b) binding to a tumor-associated antigen on a tumor cell;
- c) binding via its Fc-portion to an Fc-receptor positive cell, to obtain an intra-operatively salvaged blood containing cell aggregates, wherein said cell aggregates comprise said trifunctional bispecific antibody and/or said scaffold protein;
- (iii) separating an erythrocyte concentrate from the intra-operatively salvaged blood obtained from step (ii) via centrifugation;
- (iv) washing said erythrocyte concentrate from step (iii);
- (v) filtering the erythrocyte concentrate from step (iv) to remove residual of said aggregates and/or residual of said cell-bound trifunctional bispecific antibody and/or scaffold protein.
A trifunctional antibody which comprises the following properties:
- a) binding to a T cell;
- b) binding to a tumor-associated antigen on a tumor cell;
- c) binding via its Fc-portion to an Fc-receptor positive cell, for use in a method of treating tumor or cancer, comprising
- (i) collecting an intra-operatively salvaged blood which may contain immune cells and tumor cells;
- (ii) contacting said intra-operatively salvaged blood from step (I) with said trifunctional antibody to obtain an intra-operatively salvaged blood containing cell aggregates, wherein said cell aggregates comprise said trifunctional antibody;
- (iii) separating an erythrocyte concentrate from the intra-operatively salvaged blood obtained from step (ii) via centrifugation, preferably by density gradient centrifugation;
- (iv) washing said erythrocyte concentrate from step (iii);
- (v) filtering the erythrocyte concentrate from step (iv) to remove residual of said aggregates and/or residual of said cell-bound trifunctional antibody.
Dependencies are inferred from the claim text.